Tag: Feluda

Covid-19-test-in-India
DCGI Approves Commercial Launch Of Low Cost COVID-19 Paper Test Kit 'Feluda'

New Delhi: The Drugs Controller General of India has approved the commercial launch of ‘Feluda’, the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of Scientific and Industrial Research (CSIR) said on Saturday. This test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of SARS-CoV-2 virus, CSIR […]

  • Monday, 12 April 2021
scrollToTop